Covered recipient · General Payments record
ASTRID BELALCAZAR PORTACIO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$2,327.35
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.37 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $135.49 | 6 |
| CSL Behring | $68.50 | 2 |
| ABBVIE INC. | $65.31 | 2 |
| Octapharma USA, Inc. | $44.41 | 2 |
| EISAI INC. | $33.27 | 2 |
| GENZYME CORPORATION | $28.29 | 1 |
| Coherus Biosciences Inc. | $27.34 | 1 |
| Deciphera Pharmaceuticals Inc. | $26.62 | 1 |
| PFIZER INC. | $23.22 | 1 |
| Stemline Therapeutics Inc. | $22.33 | 1 |
| Janssen Biotech, Inc. | $19.32 | 1 |
| BeiGene USA, Inc. | $17.89 | 1 |
| Gilead Sciences, Inc. | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.97 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103302208 | CMS |
| ABBVIE INC. | $31.34 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103302210 | CMS |
| BeiGene USA, Inc. | $17.89 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120863368 | CMS |
| Celgene Corporation | $16.61 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101122198 | CMS |
| Celgene Corporation | $21.85 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101122204 | CMS |
| Celgene Corporation | $32.68 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101122214 | CMS |
| Celgene Corporation | $16.15 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101122228 | CMS |
| Celgene Corporation | $17.60 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101122246 | CMS |
| Celgene Corporation | $30.60 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101122248 | CMS |
| Coherus Biosciences Inc. | $27.34 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147273709 | CMS |
| CSL Behring | $34.25 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134644077 | CMS |
| CSL Behring | $34.25 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134644091 | CMS |
| Deciphera Pharmaceuticals Inc. | $26.62 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145872229 | CMS |
| Eisai Inc. | $20.15 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110732124 | CMS |
| Eisai Inc. | $13.12 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110732122 | CMS |
| GENZYME CORPORATION | $28.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139729674 | CMS |
| Gilead Sciences, Inc. | $13.38 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133797825 | CMS |
| Janssen Biotech, Inc. | $19.32 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078264497 | CMS |
| Octapharma USA, Inc. | $21.19 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142312673 | CMS |
| Octapharma USA, Inc. | $23.22 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142312675 | CMS |
| PFIZER INC. | $23.22 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131738541 | CMS |
| Stemline Therapeutics Inc. | $22.33 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142958454 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.